Certolizumab pegol


( Last Updated : September 7, 2018)
Generic Name:
Certolizumab pegol
Project Status:
Complete
Therapeutic Area:
Arthritis, psoriatic
Manufacturer:
UCB Canada Inc.
Call for patient/clinician input open:
Brand Name:
Cimzia
Project Line:
Reimbursement Review
Project Number:
SR0394-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Arthritis, psoriatic
Recommendation Type:
List with criteria/condition
Final Recommendation: